Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

Not Applicable

Completed

Conditions: Prostate Cancer

First Posted Date: 2024-04-12

Last Posted Date: 2024-11-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 380

Registration Number: NCT06362291

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Phase 2

Recruiting

Conditions: Salivary Gland Neoplasm Duct

Interventions: Drug: Rezvilutamide
Drug: Leuprolide Acetate

First Posted Date: 2024-04-04

Last Posted Date: 2024-04-04

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 37

Registration Number: NCT06348264

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University School and Hospital of Stomatology, Beijing, Beijing, China

A Multicenter, Prospective Cohort Study of Preserved Ratio Impaired Spirometry(PRISm) in a Population

Recruiting

Conditions: COPD

First Posted Date: 2024-04-01

Last Posted Date: 2024-04-01

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 2000

Registration Number: NCT06340295

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China
🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

and more 2 locations

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

Not Applicable

Recruiting

Conditions: Atrophic Gastritis With Low-grade Intraepithelial Neoplasia

Interventions: Drug: Moluodan granules
Drug: Fuzhegn Nizeng Decoction

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 144

Registration Number: NCT06324825

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Not Applicable

Recruiting

Conditions: Renal Cell Carcinoma, Clear Cell, Somatic

Interventions: Drug: Fruquintinib and Everolimus

First Posted Date: 2024-03-19

Last Posted Date: 2024-03-19

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 36

Registration Number: NCT06317298

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

Not Applicable

Recruiting

Conditions: Neoplasms

Interventions: Drug: 68Ga-Her2-affibody

First Posted Date: 2024-03-04

Last Posted Date: 2024-12-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 30

Registration Number: NCT06289517

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Not Applicable

Recruiting

Conditions: Hypothermia
Delirium
Long-term Survivors
Cancer Surgery

First Posted Date: 2024-02-13

Last Posted Date: 2024-06-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 3992

Registration Number: NCT06256354

Locations: 🇨🇳
The Pepple's Hospital of Chizhou, Chizhou, Anhui, China
🇨🇳
Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

and more 18 locations

The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)

Phase 4

Recruiting

Conditions: Potassium Imbalance
Cardiac Arrhythmia
Dialysis; Complications

Interventions: Drug: sodium zirconium cyclic silicate

First Posted Date: 2024-02-05

Last Posted Date: 2024-02-05

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 61

Registration Number: NCT06242041

Locations: 🇨🇳
Peking University first hospital hemodialysis center, Beijing, Beijing, China

Liposomal vs. Conventional Bupivacaine for Pain Control

Phase 4

Recruiting

Conditions: Regional Block
Paravertebral Block
Local Anesthetics
Analgesia

Interventions: Drug: Performing paravertebral nerve block with bupivacaine
Drug: Performing paravertebral nerve block with lipo-bupivacaine

First Posted Date: 2024-01-30

Last Posted Date: 2024-04-03

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 60

Registration Number: NCT06231355

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery

Phase 2

Not yet recruiting

Conditions: Upper Urinary Tract Urothelial Carcinoma

Interventions: Other: Standard of Care
Drug: Disitamab Vedotin
Radiation: Radiotherapy

First Posted Date: 2024-01-18

Last Posted Date: 2024-01-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 60

Registration Number: NCT06210490

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy